Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Ost

Showing results (121-130 of 334) with videos related to

Pageof 34
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 24, 2025
The 2024 State of Science report from the European Organisation for Research and Treatment of Cancer's Radiation Oncology Scientific CouncilDaniel Portik, Denis Lacombe, Corinne Faivre-Finn, et al.
Clinical Genitourinary Cancer|September 27, 2012
Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapyPatrick Berkovic, Gert De Meerleer, Louke Delrue, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2023
Microbiome and metabolome dynamics during radiotherapy for prostate cancerWilleke Danckaert, Mathieu Spaas, Nora Sundahl, et al.
Clinical Genitourinary Cancer|January 26, 2018
Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain ReactionSarah Buelens, Tom Claeys, Bert Dhondt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2013
Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMATJoke Werbrouck, Piet Ost, Valerie Fonteyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2008
Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomyGert De Meerleer, Valérie Fonteyne, Sabine Meersschout, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting reportGillian Thomas, Elizabeth Eisenhauer, Robert G Bristow, et al.
Cancer|May 26, 2005
Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patientsWim Duthoy, Tom Boterberg, Filip Claus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2016
Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion: Analysis of genito-urinary and rectal toxicityNora Sundahl, Gert De Meerleer, Geert Villeirs, et al.
European Urology Oncology|March 22, 2021
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic ReviewAndrea Farolfi, Boris Hadaschik, Freddie C Hamdy, et al.
Pageof 34

Showing results (121-130 of 334) with videos related to

Sort By:
Pageof 34
European Journal of Cancer (Oxford, England : 1990)|March 24, 2025
The 2024 State of Science report from the European Organisation for Research and Treatment of Cancer's Radiation Oncology Scientific CouncilDaniel Portik, Denis Lacombe, Corinne Faivre-Finn, et al.
Clinical Genitourinary Cancer|September 27, 2012
Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapyPatrick Berkovic, Gert De Meerleer, Louke Delrue, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2023
Microbiome and metabolome dynamics during radiotherapy for prostate cancerWilleke Danckaert, Mathieu Spaas, Nora Sundahl, et al.
Clinical Genitourinary Cancer|January 26, 2018
Prognostic and Therapeutic Implications of Circulating Androgen Receptor Gene Copy Number in Prostate Cancer Patients Using Droplet Digital Polymerase Chain ReactionSarah Buelens, Tom Claeys, Bert Dhondt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 25, 2013
Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMATJoke Werbrouck, Piet Ost, Valerie Fonteyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2008
Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomyGert De Meerleer, Valérie Fonteyne, Sabine Meersschout, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2020
The European Organisation for Research and Treatment of Cancer, State of Science in radiation oncology and priorities for clinical trials meeting reportGillian Thomas, Elizabeth Eisenhauer, Robert G Bristow, et al.
Cancer|May 26, 2005
Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patientsWim Duthoy, Tom Boterberg, Filip Claus, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 11, 2016
Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion: Analysis of genito-urinary and rectal toxicityNora Sundahl, Gert De Meerleer, Geert Villeirs, et al.
European Urology Oncology|March 22, 2021
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic ReviewAndrea Farolfi, Boris Hadaschik, Freddie C Hamdy, et al.
Pageof 34